Suppr超能文献

一种基于荧光共振能量转移的蛋白酶体催化亚基组成鉴定方法。

A FRET-based approach for identification of proteasome catalytic subunit composition.

作者信息

Park Ji Eun, Wu Ying, Carmony Kimberly Cornish, Miller Zachary, Sharma Lalit Kumar, Lee Do-Min, Kim Doo-Young, Lee Wooin, Kim Kyung-Bo

机构信息

Department of Pharmaceutical Sciences, University of Kentucky, Lexington, Kentucky, USA 40536-0596.

出版信息

Mol Biosyst. 2014 Feb;10(2):196-200. doi: 10.1039/c3mb70471h.

Abstract

Mammalian cells have two main types of proteasomes, the constitutive proteasome and the immunoproteasome, each containing a distinct set of three catalytic subunits. Recently, additional proteasome subtypes containing a non-standard mixture of catalytic subunits have gained increasing attention, especially due to their presence in cancer settings. However, practical methods for identifying proteasome subtypes have been lacking. Here, we report the development of the first fluorescence resonance energy transfer (FRET)-based strategy that can be utilized to identify different proteasome subtypes present within cells. We have developed FRET donor- and acceptor-probes that are based on previously reported peptide epoxyketones and selectively target individual proteasome catalytic subunits. Using the purified proteasome and cancer cell lysates, we demonstrate the feasibility of a FRET-based approach for determining the catalytic subunit composition of individual 20S proteasome subtypes. Ultimately, this approach may be utilized to study the functions of individual proteasome subtypes in cells.

摘要

哺乳动物细胞有两种主要类型的蛋白酶体,即组成型蛋白酶体和免疫蛋白酶体,每种都包含一组不同的三个催化亚基。最近,含有非标准催化亚基混合物的其他蛋白酶体亚型受到越来越多的关注,特别是因为它们存在于癌症环境中。然而,一直缺乏鉴定蛋白酶体亚型的实用方法。在这里,我们报告了第一种基于荧光共振能量转移(FRET)的策略的开发,该策略可用于识别细胞内存在的不同蛋白酶体亚型。我们开发了基于先前报道的肽环氧酮的FRET供体和受体探针,并选择性地靶向单个蛋白酶体催化亚基。使用纯化的蛋白酶体和癌细胞裂解物,我们证明了基于FRET的方法用于确定单个20S蛋白酶体亚型的催化亚基组成的可行性。最终,这种方法可用于研究细胞中单个蛋白酶体亚型的功能。

相似文献

1
A FRET-based approach for identification of proteasome catalytic subunit composition.
Mol Biosyst. 2014 Feb;10(2):196-200. doi: 10.1039/c3mb70471h.
5
Purification and proteomic analysis of 20S proteasomes from human cells.
Methods Mol Biol. 2008;432:301-20. doi: 10.1007/978-1-59745-028-7_21.
6
Gel-based proteomics analysis of the heterogeneity of 20S proteasomes from four human pancreatic cancer cell lines.
Proteomics Clin Appl. 2011 Oct;5(9-10):484-92. doi: 10.1002/prca.201000149. Epub 2011 Jul 13.
7
Structure-Based Design of Fluorogenic Substrates Selective for Human Proteasome Subunits.
Chembiochem. 2020 Nov 16;21(22):3220-3224. doi: 10.1002/cbic.202000375. Epub 2020 Jul 29.
8
Development and Application of a Sensitive Peptide Reporter to Discover 20S Proteasome Stimulators.
ACS Comb Sci. 2018 May 14;20(5):269-276. doi: 10.1021/acscombsci.7b00193. Epub 2018 Mar 23.
9
Comprehensive mass spectrometric analysis of the 20S proteasome complex.
Methods Enzymol. 2005;405:187-236. doi: 10.1016/S0076-6879(05)05009-3.
10
Purification and separation of the 20S immunoproteasome from the constitutive proteasome and identification of the subunits by LC-MS.
Protein Expr Purif. 2013 Feb;87(2):100-10. doi: 10.1016/j.pep.2012.10.009. Epub 2012 Nov 9.

引用本文的文献

1
Site-Specific Proteasome Inhibitors.
Biomolecules. 2021 Dec 31;12(1):54. doi: 10.3390/biom12010054.
2
Fluorescent Probes with Unnatural Amino Acids to Monitor Proteasome Activity in Real-Time.
ACS Chem Biol. 2020 Sep 18;15(9):2588-2596. doi: 10.1021/acschembio.0c00634. Epub 2020 Aug 26.
3
Highlighting the Proteasome: Using Fluorescence to Visualize Proteasome Activity and Distribution.
Front Mol Biosci. 2019 Mar 22;6:14. doi: 10.3389/fmolb.2019.00014. eCollection 2019.
5
Polymer micelle formulation for the proteasome inhibitor drug carfilzomib: Anticancer efficacy and pharmacokinetic studies in mice.
PLoS One. 2017 Mar 8;12(3):e0173247. doi: 10.1371/journal.pone.0173247. eCollection 2017.
7
Modelling proteasome and proteasome regulator activities.
Biomolecules. 2014 Jun 20;4(2):585-99. doi: 10.3390/biom4020585.

本文引用的文献

1
A novel role of proteasomal β1 subunit in tumorigenesis.
Biosci Rep. 2013 Jul 16;33(4):e00050. doi: 10.1042/BSR20130013.
2
Mixed proteasomes function to increase viral peptide diversity and broaden antiviral CD8+ T cell responses.
J Immunol. 2013 Jul 1;191(1):52-9. doi: 10.4049/jimmunol.1300802. Epub 2013 May 24.
3
Activity-based imaging probes of the proteasome.
Cell Biochem Biophys. 2013 Sep;67(1):91-101. doi: 10.1007/s12013-013-9626-4.
4
Molecular alterations in proteasomes of rat liver during aging result in altered proteolytic activities.
Age (Dordr). 2014 Feb;36(1):57-72. doi: 10.1007/s11357-013-9543-x. Epub 2013 May 22.
5
Activity-based near-infrared fluorescent probe for LMP7: a chemical proteomics tool for the immunoproteasome in living cells.
Chembiochem. 2012 Sep 3;13(13):1899-903. doi: 10.1002/cbic.201200307. Epub 2012 Jul 17.
7
Distinct proteasome subpopulations in the alveolar space of patients with the acute respiratory distress syndrome.
Mediators Inflamm. 2012;2012:204250. doi: 10.1155/2012/204250. Epub 2012 Jan 29.
8
Changes in 20S subunit composition are largely responsible for altered proteasomal activities in experimental autoimmune encephalomyelitis.
J Neurochem. 2012 May;121(3):486-94. doi: 10.1111/j.1471-4159.2012.07699.x. Epub 2012 Mar 14.
9
Assembly and function of the proteasome.
Methods Mol Biol. 2012;832:315-37. doi: 10.1007/978-1-61779-474-2_22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验